Multinuclear NMR spectroscopy and antitumor activity of novel platinum(II) complexes with 5,7-disubstituted-1,2,4-triazolo[1,5-a]pyrimidines

Novel platinum(II) complexes with 5,7-disubstituted-1,2,4-triazolo[1,5-a]pyrimidines have been synthesized and characterized by infrared and multinuclear magnetic resonance spectroscopic techniques (1H, 13C, 15N, 195Pt). The complexes are of two types: [PtCl2(L)2] and [PtCl2(NH3)(L)], where L=5,7-diphenyl-1,2,4-triazolo[1,5-a]pyrimidine (dptp) and 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine (dbtp). Significant 15N NMR upfield shifts (92-95 ppm) were observed for N(3) atom indicating this nitrogen atom as a coordination site. The molecular structure suggest that Pt(II) ion has the square planar geometry with N(3) bonded 5,7-disubstituted-1,2,4-triazolo[1,5-a]pyrimidines, N-bonded second ligand (NH3 for cis-[PtCl2(NH3)(L)] or, respectively, 5,7-disubstituted-1,2,4-triazolo[1,5-a]pyrimidines for cis-[PtCl2L2]) and two cis chloride anions. The antiproliferative activity in vitro of complexes (1-4) have been tested against the cells of four human cell lines: SW707 rectal adenocarcinoma, A549 non-small cell lung carcinoma, T47D breast cancer and HCV29T bladder cancer. The results indicate a moderate antiproliferative activity of (4) against the cells of rectal, breast and bladder cancer and a marked and selective cytotoxic effect of (1-3) against the cells of all studied human cancer lines.     

1,2,4-triazolo[4,3-a]pyrimidines: a new kind of ligands. Structure of the silver(I) dimer with the 7-oxo derivative

This paper describes the silver dinuclear complex [Ag₂L₂(NO₃)₂] · 2H₂O, where L represents the bridging ligand 7,8-dihydro-7-oxo-1,2,4-triazolo[4,3-a]pyrimidine, this being the first example of a coordination compound of a 1,2,4-triazolo[4,3-a]pyrimidine derivative. As a difference with the most studied 1,2,4-triazolo[1,5-a]pyrimidine derivatives, the coordination takes place through the contiguous nitrogen atoms of the triazole ring, closing a six member Ag₂N₄ core with a higher intermetallic distance, 3.4791(3) Å. Linear coordination of silver is not possible in this geometry, so flat trigonal coordination involving also the nitrate counteranion is found instead.     

New copper(II), nickel(II) and zinc(II) complexes with 1,2,4-triazolo[1,5-a]pyrimidines and the chelating ligand 1,3-propanediamine: An unexpected coordination behavior for the 7-amine-derivative

Five new metal complexes with the metal ions Cu(II), Ni(II) and Zn(II) and containing 1,2,4-triazolo[1,5-a]pyrimidine derivatives and 1,3-propanediamine (tn) are described. The structural morphology of these coordination compounds depends on the triazolopyrimidine derivative used, being mononuclear for 5,7-dimethyl-1,2,4-triazolo[1,5-a]pyrimidine (dmtp) and 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one (HmtpO), and 1D-polymeric for 7-amine-1,2,4-triazolo[1,5-a]pyrimidine (7atp). In the 7atp case, this ligand does not coordinate through N3 atom, as expected, but through N1, N4 and N71 in a bridging fashion. This unexpected coordination mode seems to be induced by the stability of the polynuclear metal complex in presence of tn ligand. All isolated metal complexes have been characterized by single-crystal X-ray diffraction, IR and UV-Vis spectroscopies, and EPR measurements. Moreover, luminescence measurements have been carried out for 7atp ligand and its polynuclear complex with Zn(II).     

Synthesis, spectroscopical characterization and the biological activity in vitro of new platinum(II) complexes with imidazo[1,5-a]-1,3,5-triazine derivatives and dimethylsulfoxide

A series of platinum(II) complexes with 6,8-dimethylimidazo[1,5-a]-1,3,5-triazin-4(3H)-one (6,8-DiMe-4-O-IMT) (I) and 6,8-dimethyl-2-thioxo-2,3-dihydroimidazo[1,5-a]-1,3,5-triazin-4(1H)-one (6,8-DiMe-4-O-2-S-IMT) (II) of formula trans-[PtCl₂(dmso)(6,8-DiMe-4-O-IMT)] (1a) and trans-[PtCl₂(dmso)(6,8-DiMe-4-O-2-S-IMT)] (2a) have been prepared and characterized with ¹H, ¹³C, ¹⁵N, ¹⁹⁵Pt NMR and IR. Significant ¹⁵N NMR upfield coordination shifts (81-96 ppm) of N(7) atom indicate this nitrogen atom as a coordination site. The multinuclear NMR and IR spectra indicate the square planar geometry with N(7) bonded heterocycles, S-bonded dimethylsulfoxide and two trans chloride anions. The platinum(II) complexes were tested for their antiproliferative activity in vitro against the cells of four human cell lines: SW707 rectal adenocarcinoma, A549 non-small cell lung carcinoma, T47D breast cancer and HCV29T bladder cancer. The activity of (1a, 2a) was lower than that of cisplatin.     

Synthesis, characterisation and solution behaviour of fluoroalkyl phosphoryl complexes of tin tetrachloride

The synthesis, characterisation and solution behaviour of a series of octahedral complexes SnCl₄·2L (L = R₂NP(O)(OCH₂CF₃)₂; R = Me (1); Et (2) or L = P(O)(OCH₂R_f)₃; R_f = CF₃ (3); C₂F₅ (4)) are described. Complexes 1-4 were prepared from SnCl₄ and 2 equiv. of the ligand, L, in anhydrous CH₂Cl₂ solution. The adducts have been characterised by multinuclear (¹H, ³¹P and ¹¹⁹Sn) NMR, IR spectroscopy and elemental analysis. In dichloromethane solution, the NMR data showed the presence of a mixture of cis and trans isomers for 1 and 2 and only the cis isomer for 3 and 4. The difference could be interpreted in terms of the electronic effects of the substituents on the phosphorus atom of the ligand. In addition, the solution structure of the complexes studied by variable temperature ³¹P-{¹H} and ¹H NMR in the presence of excess ligand indicated that the ligand exchange on the cis isomer dominates the chemistry. The metal-ligand exchange barriers were estimated to be 13.38 and 11.39 kcal/mol for 1 and 3, respectively. The results are discussed and compared with those previously reported for the related hexamethylphosphoramide adduct, SnCl₄·2HMPA.     

Synthesis and structure determination of two new dinuclear end-to-end doubly bridged azido- and thiocyanato-copper(II) complexes derived from diethyldiethylenetriamine

Herein, we report the synthesis and characterization of two new dinuclear bridged azido and bridged thiocyanato complexes: [Cu₂(Et₂dien)₂(μ_1,3-N₃)₂](ClO₄)₂ (1) and [Cu₂(Et₂dien)₂(μ_N,S-NCS)₂]-(ClO₄)₂ (2) where Et₂dien = N,N-diethyldiethylenetriamine. In both complexes, the two copper centers are linked by two azide or two thiocyanate groups in end-to-end bonding fashion. The copper ions are penta-coordinated by three N-atoms of the Et₂dien ligand, one N atom from the bridging azido in 1 or from the thiocyanato group in 2. The fifth coordination site is occupied by N or S atom from the second bridging azide or thiocyanate ligand, respectively. The coordination geometry around the Cu(II) ions in the two complexes may be described as close to square pyramidal (SP) stereochemistry with severe distortion to trigonal bipyramidal (TBP) stereochemistry. The intradimer Cu?Cu distances are 5.264(1) and 5.571(1) Å for the azido and thiocyanato complex, respectively. The IR stretching frequencies of the azido, and the thiocyanato, ν(NCS⁻) groups in the 2030-2120 cm⁻¹ region are discussed in relation to other related species. The visible spectra of the complexes studied in different solvents reveal the assigned predominant SP stereochemistry in solution with the presence of a pronounced amount of TBP geometry in the thiocyanato complex. Moreover, the complexes undergo solvolysis through bond rupture and displacement of one of the bridged azido or thiocyanato ligands.     

Combining coordination chemistry with hydrogen bonds: perturbation of the structures by interaction of an organotin(IV) complex with O-donor solvent molecules

We have examined the role of different solvents in the crystallisation process of cis-octahedral, diphenyltin(IV)-bis-cupferronato complex, Ph₂Sn(cupf)₂ (1), where . The Mössbauer spectra of frozen chloroform solution of 1 revealed the presence of cis and trans isomers. This cis-trans isomerisation was investigated by Mössbauer spectroscopy and the results inspired the synthesis of two new heptacoordinated derivatives: Ph₂Sn(cupf)₂(H₂O) (2) and Ph₂Sn(cupf)₂(EtOH) · EtOH (3). In both compounds, the O-donor solvent molecules (H₂O, EtOH) form novel Sn-O bonds with the Ph₂Sn(IV) centre of 1, consequently the phenyl groups attached to tin undergo an intramolecular rearrangement. Compound 2 contains O-H ? O hydrogen bonded infinite chains. In compound 3, O-H ? O hydrogen-bonds and short O ? O contacts assemble the complexes and uncoordinated solvent molecules into dimeric supramolecules. These solvents have structure-determining roles at both molecular and supramolecular levels: at molecular level the coordination of solvent determines intramolecular rearrangement by changing the conformation of the parent unsolvated complex, whilst at supramolecular level they control the association of solvated molecules via hydrogen bonds.     

Synthesis and characterization of Pd(II) and Pt(II) complexes with triazolopyrimidine derivatives: The crystal structure of [Pd2L2Cl4] where L = 5,7-dimethyl-1,2,4-triazolo[1,5-a]pyrimidine

The Pd(II) and Pt(II) complexes with triazolopyrimidine C-nucleosides L¹ (5,7-dimethyl-3-(2′,3′,5′-tri-O-benzoyl-β-d-ribofuranosyl-s-triazolo)[4,3-a]pyrimidine), L² (5,7-dimethyl-3-β-d-ribofuranosyl-s-triazolo[4,3-a]pyrimidine) and L³ (5,7-dimethyl[1,5-a]-s-triazolopyrimidine), [Pd(en)(L¹)](NO₃)₂, [Pd(bpy)(L¹)](NO₃)₂, cis-Pd(L³)₂Cl₂, [Pd₂(L³)₂Cl₄] · H₂O, cis-Pd(L²)₂Cl₂ and [Pt₃(L¹)₂Cl₆] were synthesized and characterized by elemental analysis and NMR spectroscopy. The structure of the [Pd₂(L³)₂Cl₄] · H₂O complex was established by X-ray crystallography. The two L³ ligands are found in a head to tail orientation, with a Pd?Pd distance of 3.1254(17) Å. L¹ coordinates to Pd(II) through N8 and N1 forming polymeric structures. L² coordinates to Pd(II) through N8 in acidic solutions (0.1 M HCl) forming complexes of cis-geometry. The Pd(II) coordination to L² does not affect the sugar conformation probably due to the high stability of the C-C glycoside bond.     

6-Nitrotriazolo[1,5-<Emphasis Type="Italic">a</Emphasis>]pyrimidines as promising structures for pharmacotherapy of septic conditions

Promising 6-nitro-1,2,4-triazolo[1,5-a]pyrimidine analogues, structural analogues of synthetic inhibitors of adenosine receptors, were sorted out on the basis of quantum-chemical calculations. The compounds were synthesized by nitration and chlorodeoxygenation reactions. The in vivo activity of 6-nitroheterocycles was studied and the affinity to adenosine receptor A_2A was demonstrated in regard to septic conditions.     

The crystal and molecular structures of dichlorobis (5,7-diphenyl-1,2,4-triazolo[1,5-α]pyrimidine)zinc(II) (1) and dichlorobis(5,7-diphenyl-1,2,4-triazolo[1,5-α]pyrimidine)cobalt(II) (2)

The synthesis and structural studies of the new ligand 5,7-diphenyl-1,2,4-triazolo[1,5-α]pyrimidine (dptp), which can be considered as an analog of purine, and its complexes are described. Complexes were characterised by spectral measurements (IR, NMR, UV-Vis). In addition X-ray structural analysis was performed. Crystals of [Zn(C₁₇H₁₂N₄)₂Cl₂] (1) revealed the following parameters: M_r = 680.9; monoclinic for 2188 observed reflections. [Co(C₁₇H₁₂N₄)₂Cl₂] (2); M_r = 674.4; monoclinic for 1630 observed reflections.     

Potent and selective adenosine A2A receptor antagonists: 1,2,4-Triazolo[1,5-c]pyrimidines

Antagonism of the adenosine A_2a receptor offers great promise in the treatment of Parkinson’s disease. In the course of exploring pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine A_2A antagonists, which led to clinical candidate SCH 420814, we prepared 1,2,4-triazolo[1,5-c]pyrimidines with potent and selective (vs A₁) A_2a antagonist activity, including oral activity in the rat haloperidol-induced catalepsy model. Structure–activity relationships and plasma levels are described for this series.     

Synthesis and characterization of Co(II), Ni(II), and Cu(II) complexes containing an eight-membered disulfanenitrile chelating ring

New types of λ⁶-sulfanenitrile-transition metal complexes, [MCl₂(ndsdsd)] (1) and [M(ndsdsd)₂]Cl₂ (2) (M = Co(II), Ni(II), Cu(II)), were obtained by reacting MCl₂ with bis[(nitrilo(diphenyl)-λ⁶-sulfanyl)](diphenyl)-λ⁶-sulfanediimide Ph₂S(N-(Ph₂)SN)₂ (ndsdsd). The crystal structures of these complexes have been elucidated by X-ray crystallographic analysis. The results revealed that, in complexes 1 and 2, the two terminal nitrogen atoms chelate to the metal center to form an eight-membered sulfur-nitrogen ring.     

Potent and selective adenosine A(2A) receptor antagonists: [1,2,4]-triazolo[4,3-c]pyrimidin-3-ones

Antagonism of the adenosine A_2A receptor affords a possible treatment of Parkinson’s disease. In the course of investigating pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine A_2A antagonists, we prepared [1,2,4]-triazolo[4,3-c]pyrimidin-3-ones with potent and selective (vs A₁) A_2A antagonist activity. Structure-activity relationships are described for this series.     

New assembled Fe-trans-1,2-bis(4-pyridyl)ethylene-NCS(NCSe) complexes - hydrogen bonded and π-π interacted structure and grid structure enclathrating ligand

Reaction of FeSO₄ · 7H₂O with trans-1,2-bis(4-pyridyl)ethylene (tvp) and NaNCS in the mixed solvent of water and ethanol gave rise to the formation of different coordination polymers. One (Fe(tvp)₂(NCS)₂(H₂O)₂) is hydrogen bonded and π-π interacted structure, while the other ([Fe(tvp)₂(NCS)₂][0.5(tvp · 2EtOH)]) is 2D grid structure, which enclathrates tvp · 2EtOH. This enclathrated tvp · 2EtOH interacts with the two 2D grid sheets to form 3D structure. The same reaction was carried out with KNCSe instead of NaNCS (Fe(tvp)₂(NCSe)₂(H₂O)₂). ⁵⁷Fe Mössbauer spectra revealed that all the present assembled complexes are in the Fe^II high-spin state. The dissociation behavior of enclathrated molecule and ligand was investigated by TG, and the resultant electronic state of iron atom was studied by ⁵⁷Fe Mössbauer spectroscopy.     

Synthesis, characterization and crystal structures of homo- and hetero-substituents containing trans six-coordinate tin(IV) complexes of H2tmtaa (5,14-dihydro-6,8,15,17-tetramethyldibenzo[b,i][1,4,8,11]tetraazacyclotetradecine), and the solid state NMR spectra study of Sn

The reaction of Sn(tmtaa)Cl₂ (H₂tmtaa=5,14-dihydro-6,8,15,17-tetramethyldi-benzo[b,i][1,4,8,11]tetraazacyclotetradecine) and ammonium thiocyanate or sodium azide under a mild condition resulted in trans six-coordinate tmtaa tin(IV) complexes, Sn(tmtaa)X₂ (X=NCS, 1; X=N₃, 2). However, the treatment of Sn(tmtaa)Cl₂ and sodium picrate produced Sn(tmtaa)(Cl)(OC₆H₂ (2,4,6-3NO₂)) (3). Only one chloro atom of Sn(tmtaa)Cl₂ was substituted because of low nucleophilicity of the 2,4,6-trinitrophenolic anion in 3. Furthermore, because of the steric hindrance between the 2,4,6-trinitrophenolic group and the tmtaa ligand, which has a non-planar, saddle-shaped conformation, two chloro atoms cannot be substituted by two 2,4,6-trinitrophenolic groups simultaneously. All complexes were characterized by IR spectra, UV spectra, mass spectra, NMR spectra and elemental analyses, as well as DSC measurements. X-ray crystal structures of 1 and 3 reveal that the complexes retain the characteristic saddle-shaped configuration of H₂tmtaa but have adopted the trans geometry. Solid state ¹¹⁹Sn NMR spectroscopy was used to study the bonding environment in the series of six-coordinate trans Sn(IV) tmtaa complexes. It can be found that the ¹¹⁹Sn chemical shifts of the Sn(IV) tmtaa complexes are almost not influenced by the substituents.     

Syntheses and electrochemical properties of ruthenium(II) complexes with 4,4-bipyrimidine and 4,4-bipyrimidinium ligands

The syntheses and electrochemical properties of novel ruthenium(II) polypyridyl complexes with 4,4^′-bipyrimidine, [Ru(trpy)(bpm)Cl](X) ([1](X; X=PF₆⁻, BF₄⁻)) and with a quaternized 4,4^′-bipyrimidinium ligand, [Ru(trpy)(Me₂bpm)Cl](BF₄)₃ ([2](BF₄)₃) (trpy=2,2^′:6^′,2″-terpyridine, bpm=4,4^′-bipyrimidine, Me₂bpm=1,1^′-dimethyl-4,4^′-bipyrimidinium) are presented. The bpm complex [1]⁺ was prepared by the reaction of Ru(trpy)Cl₃ with 4,4^′-bipyrimidine in EtOH/H₂O. The structural characterization of [1]⁺ revealed, that the bpm ligand coordinated to the ruthenium atom with the bidentate fashion. Diquaternization of the non-coordinating nitrogen atoms on bpm of [1]⁺ by (CH₃)₃OBF₄ in CH₃CN gave [2](BF₄)₃. The electrochemical and spectroelectrochemical properties of the complexes are described.     

Organotin(IV) 4-methoxyphenylethanoates: Synthesis, spectroscopic characterization, X-ray structures and in vitro anticancer activity against human prostate cell lines (PC-3)

A series of organotin(IV) carboxylates, [Bu₂SnL₂] (1), [Et₂SnL₂] (2), [Me₂SnL₂] (3), [Bu₃SnL]_n(4), [Me₆Sn₂L₂]_n(5), [Ph₃SnL]_n(6) and [Oct₂SnL₂] (7), where L = O₂CCH₂C₆H₄OCH₃-4, have been synthesized. These complexes have been characterized by elemental analysis, FT-IR and multinuclear NMR (¹H, ¹³C and ¹¹⁹Sn). Based on spectroscopic results, the ligand appeared to coordinate to the Sn atom through COO moiety. Single crystal analysis has shown a bridging behavior of ligand in tributyl- and trimethyltin(IV) derivatives, and a chelating bidentate mode in diethyltin(IV) complex. Bioassay results have shown that these compounds have good antibacterial, antifungal and antitumor activity. The activity against prostate cancer cell lines (PC-3) decreased in the order 1 > 5 > 2 > 3 > 7.     

Mixed ligand complexes of osmium(II)-2,2-bipyridine: synthesis, spectral characterization and electrochemical properties of bis-chelated-arylazoimidazole-bipyridine-osmium(II) and X-ray crystal structure of [(2,2-bipyridine)-bis-{1-methyl-2-(p-tolylazo)imidazole}osmium(II) hexafluorophosphate

Reaction of ctc-OsBr₂(RaaiR^′)₂ [RaaiR^′=1-alkyl-2-(arylazo)imidazole, p-R-C₆H₄-NN-C₃H₂-NN-1-R^′, where R=H (a), Me (b), Cl (c) and R^′=Me (2), Et (3) and CH₂Ph (4)] with 2,2^′-bipyridine (bpy) in presence of AgNO₃ in EtOH followed by the addition of NH₄PF₆ afforded a mixed ligand complex [Os(bpy)(RaaiR^′)₂](PF₆)₂. The structure of the complex, in one case [Os(bpy)(MeaaiMe)₂](PF₆)₂ · 4H₂O, has been confirmed by X-ray crystallography. The complexes are diamagnetic (low spin d⁶, s=0) and they show intense MLCT transition in the visible region (480-525 nm) and a weak transition at longer wavelength (>850 nm) in CH₃CN solution. Cyclic voltammetry of the complexes show two metal oxidation, Os(II)/Os(III) at 0.72-0.76 V and Os(III)/Os(IV) at 1.34-1.42 V and three successive ligand reductions.     

Cd(II)-ethylenediamine mono- and bimetallic complexes - Synthesis and characterization by Cd NMR spectroscopy and single crystal X-ray diffraction

Formation of three Cd(II)-ethylenediamine (en) complexes ([Cd(en)_n]²⁺, n = 1-3) in aqueous solution and in DMSO solvent has been established by means of ¹¹³Cd NMR spectroscopy. It is clearly shown that Cd(II)-en complexes form primarily in basic solutions. A correlation between the ¹¹³Cd NMR chemical shifts and the ethylenediamine (en) coordination number has been observed and discussed. Two single crystals with the composition [Cd₂(en)₅](ClO₄)₄ (1) and [Cd(en)₃](ClO₄)₂ (2) were prepared from aqueous solution, and their structures were determined by single crystal X-ray diffraction. Cd(II) ions are coordinated by six atoms in both compounds, 1 and 2: via five N-donor atoms and one O-donor atom forming a bimetallic complex 1, and via six N-donor atoms forming a distorted octahedral monometallic complex 2. Raman spectra of complexes 1 and 2 also provide additional evidence that the cis-form of the bridging en is present in complex 1.     

Synthesis, spectroscopic characterization, and crystal structures of two chlorodiorganotin(IV) 4-(2-methoxyphenyl)piperazine-1-carbodithioates

Two chlorodiorganotin(IV) complexes of 4-(2-methoxyphenyl)piperazine-1-carbodithioate (MPPDA) have been synthesized by 1:1 mole-ratio reactions of the parent acid (MPPDAH) with Me₂SnCl₂ or Et₂SnCl₂ in dry methanol. The products have been characterized by Raman and multinuclear NMR (¹H, ¹³C and ¹¹⁹Sn) spectroscopy, elemental analysis, and mass spectrometry. Single-crystal X-ray diffraction studies indicate that both complexes have distorted trigonal bipyramidal geometries around the central Sn atom.